SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096665
Filing Date
2024-08-14
Accepted
2024-08-14 08:00:51
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgx-20240630.htm   iXBRL 10-Q 2585929
2 EX-31.1 mgx-ex31_1.htm EX-31.1 15648
3 EX-31.2 mgx-ex31_2.htm EX-31.2 15591
4 EX-32.1 mgx-ex32_1.htm EX-32.1 13373
  Complete submission text file 0000950170-24-096665.txt   9739162

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20240630.xsd EX-101.SCH 1345598
65 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20240630_htm.xml XML 1657056
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

IRS No.: 813909017 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41949 | Film No.: 241204250
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)